This process increases the secretion of TGF-β and other tumor-promoting factors while inhibiting the secretion of anti-tumor factors, ultimately impacting the immune function of major cells within the tumor microenvironment and promoting tumor immune escape (96–101). The gene discussed is TGFB1; the disease is neoplasm.